| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a89984cd0ba1d2ebd38980ff55c59c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_64cffa2e2d9248f55895f659d8462d2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3165f44a47dd0136becbdf31d531127d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bfdf55849dda2962234b611006d86ba9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0031 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4748 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate |
2012-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fd72dfcc3e36edc3192399fb30e0f0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bb905a78e493524ef872ba3ca8dfe52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88ebbba1e0fe81d607da4e06d93c30d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a77c95ec6a9c4ed1eff9b34aeb8b725d |
| publicationDate |
2013-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013122099-A1 |
| titleOfInvention |
Polyethylene glycol-coated sodium carbonate as a pharmaceutical excipient and compositions produced from the same |
| abstract |
Non-effervescent pharmaceutical compositions having at least one particle of carbonate coated by a layer of polyethylene glycol that substantially covers the at least one carbonate particle are described. Compositions are also described where the compositions include a weakly basic therapeutic agent, a first pH-modifying agent having at least one particle of carbonate coated by a layer of polyethylene glycol, and a second pH-modifying agent. The weakly basic therapeutic agent could be, but is not limited to, zolpidem or scopolamine. Compositions including zolpidem and scopolamine are used to treat insomnia and depression, respectively. |
| priorityDate |
2008-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |